Advertisement
Singapore markets closed
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,080.29
    +9.74 (+0.19%)
     
  • Dow

    38,491.68
    -12.01 (-0.03%)
     
  • Nasdaq

    15,792.13
    +95.49 (+0.61%)
     
  • Bitcoin USD

    65,919.68
    -597.07 (-0.90%)
     
  • CMC Crypto 200

    1,429.76
    +5.66 (+0.40%)
     
  • FTSE 100

    8,065.57
    +20.76 (+0.26%)
     
  • Gold

    2,331.80
    -10.30 (-0.44%)
     
  • Crude Oil

    82.78
    -0.58 (-0.70%)
     
  • 10-Yr Bond

    4.6400
    +0.0420 (+0.91%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Is Invitae Stock a Buy Now?

Is Invitae Stock a Buy Now?

Invitae (NYSE: NVTA) shares have plummeted more than 80% this year. The genetic testing company has grown revenue over the years, but it hasn't been able to turn that revenue into profit. Instead, it's burned through cash -- and left investors wondering when and if the company can make it to profitability.